Pfizer to combine off-patent drug business with Mylan

Pfizer has agreed to merge its off-patent drugs business with generic drugmaker Mylan.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news
More News: Pfizer | Pharmaceuticals